Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.
Status:
Completed
Trial end date:
2018-03-26
Target enrollment:
Participant gender:
Summary
This clinical study is a Phase I, open-label, single-center study designed to evaluate the
pharmacokinetics profile of a single oral dose of GLPG3067 in adult male subjects with cystic
fibrosis in fed state.